In this study, we retrospectively evaluated Axl and Gas6 expression levels in lung adenocarcinoma at both the genetic and protein levels, confirming their role in carcinogenesis, which we believe will be useful clinical reference in utilizing these molecules as cancer biomarkers and future therapeutic targets for the treatment of lung cancer. The gene discussed is GAS6; the disease is lung adenocarcinoma.